LEGN

Legend Biotech (LEGN) Financial Statements

Review Legend Biotech (LEGN) financials with server-rendered company data, supporting context and links to related investor research.

Annual revenue
$1.03B
Annual gross profit
$620.80M
Annual operating income
$-136.50M
Annual net income
$-282.60M
Annual free cash flow
$-128.80M
Total assets
$1.73B
Total liabilities
$731.60M
Shareholder equity
$1.00B

Legend Biotech (LEGN) Financial Statements research

The Legend Biotech financials page brings together the latest available annual and trailing figures for revenue, profitability, cash generation and balance-sheet strength. Comparing these measures across reporting periods can reveal whether operating performance and financial resilience are improving or weakening.

Revenue and earnings should be assessed together with free cash flow, assets, liabilities and debt ratios. A single figure is not a complete investment thesis, so use the linked analysis and valuation pages to place the reported results in context.